
Macrophage Targeting AXatilimab in Idiopathic Pulmonary FIbRosis (MAXPIRe) clinical trial
Investigating axatilimab for the treatment of idiopathic pulmonary fibrosis (IPF).
Thank you for your interest.
Unfortunately, this trial isn’t available in your region at this time.
MAXPIRe is sponsored by Syndax.